UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Can we influence the negative drug attitude? Interpretation of the rejection of COVID-19 vaccine in the light of results of a pilot study

Ideggyógyászati szemle, 2022-03, Vol.75 (3-04), p.111

2022

Link zum Volltext

Verfügbarkeit prüfen

Psychological disorders and tumorous diseases

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja, 2018-09, Vol.20 (3), p.94

Lazary, Judit

2018

Link zum Volltext

Verfügbarkeit prüfen

Psychopharmacological boundaries of schizophrenia with comorbid cannabis use disorder: a critical review

Current pharmaceutical design, 2012-11, Vol.18 (32), p.4890

Lazary, Judit

2012

Link zum Volltext

Verfügbarkeit prüfen

Health Control Beliefs and Attitude Toward Treatment in Psychiatric and Non-Psychiatric Clinical Samples

Frontiers in psychiatry, 2021-04, Vol.12, p.537309-537309

2021

Link zum Volltext

Verfügbarkeit prüfen

Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder

Scientific reports, 2021-04, Vol.11 (1), p.8867-8867, Article 8867

2021

Link zum Volltext

Verfügbarkeit prüfen

Personalized medicine can pave the way for the safe use of CB1 receptor antagonists

Trends in pharmacological sciences (Regular ed.), 2011-05, Vol.32 (5), p.270-280

2011

Link zum Volltext

Verfügbarkeit prüfen

Sick leave duration as a potential marker of functionality and disease severity in depression

International journal of psychiatry in clinical practice, 2022-11, Vol.26 (4), p.406-416

2022

Link zum Volltext

Verfügbarkeit prüfen

Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitive Transcranial Magnetic Stimulation

Frontiers in psychiatry, 2022-05, Vol.13, p.806731-806731

2022

Link zum Volltext

Verfügbarkeit prüfen

Massive withdrawal symptoms and affective vulnerability are associated with variants of the CHRNA4 gene in a subgroup of smokers

PloS one, 2014-01, Vol.9 (1), p.e87141

2014

Link zum Volltext

Verfügbarkeit prüfen

Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressors

PloS one, 2015-03, Vol.10 (3), p.e0116316-e0116316

2015

Link zum Volltext

Verfügbarkeit prüfen

Investigation of circulating endothelial progenitor cells and angiogenic and inflammatory cytokines during recovery from an episode of major depression

Journal of affective disorders, 2012-02, Vol.136 (3), p.1159-1163

2012

Link zum Volltext

Verfügbarkeit prüfen

Acute effects of the first period of COVID-19 pandemic on mental state

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja, 2020-12, Vol.22 (4), p.172

Lazary, Judit

2020

Link zum Volltext

Verfügbarkeit prüfen

Highlights of peripheral biomarkers in major depressive disorder: focus on HPA-axis, inflammation and neurotrophic factors

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja, 2018-12, Vol.20 (4), p.125

Lazary, Judit

2018

Link zum Volltext

Verfügbarkeit prüfen

A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes

Journal of affective disorders, 2019-10, Vol.257, p.716-722

2019

Link zum Volltext

Verfügbarkeit prüfen

Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review

Brain research bulletin, 2019-03, Vol.146, p.51-78

2019

Link zum Volltext

Verfügbarkeit prüfen

From stone-craved genes to Michelangelo: significance and different aspects of gene-environment interaction

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja, 2017-12, Vol.19 (4), p.207

Lazary, Judit

2017

Link zum Volltext

Verfügbarkeit prüfen

Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk

European journal of endocrinology, 2008-08, Vol.159 (2), p.187

2008

Link zum Volltext

Verfügbarkeit prüfen

Smoking, nicotine and neuropsychiatric disorders

Neuroscience and biobehavioral reviews, 2010-02, Vol.34 (3), p.295-342

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological treatment and health control beliefs from the perspective of psychiatric patients: differences in attitudes

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja, 2019-12, Vol.21 (4), p.170

2019

Link zum Volltext

Verfügbarkeit prüfen

Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma

European neuropsychopharmacology, 2016-06, Vol.26 (6), p.1020-1028

2016

Link zum Volltext

Verfügbarkeit prüfen

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

Pharmacopsychiatry, 2022-03, Vol.55 (2), p.73

2022

Link zum Volltext

Verfügbarkeit prüfen

New Evidence for the Association of the Serotonin Transporter Gene (SLC6A4) Haplotypes, Threatening Life Events, and Depressive Phenotype

Biological psychiatry (1969), 2008-09, Vol.64 (6), p.498-504

2008

Link zum Volltext

Verfügbarkeit prüfen

Genetic analyses of the endocannabinoid pathway in association with affective phenotypic variants

Neuroscience letters, 2021-01, Vol.744, p.135600-135600, Article 135600

2021

Link zum Volltext

Verfügbarkeit prüfen

Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2009-12, Vol.150B (8), p.1118-1127

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(65)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(51)
Science & Technology
(37)
Life Sciences & Biomedicine
(34)
Psychiatry
(30)
Adult
(28)
Female
(27)
Male
(23)
Depression
(19)
Neurosciences & Neurology
(17)
Middle Aged
(14)
Neurosciences
(14)
Biological And Medical Sciences
(13)
Clinical Neurology
(12)
Genotype
(12)
Medical Sciences
(12)
Young Adult
(12)
Phenotype
(11)
Surveys And Questionnaires
(11)
Adult And Adolescent Clinical Studies
(10)
Pharmacology & Pharmacy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Can we influence the negative drug attitude? Interpretation of the rejection of COVID-19 vaccine in the light of results of a pilot study

Psychological disorders and tumorous diseases

Psychopharmacological boundaries of schizophrenia with comorbid cannabis use disorder: a critical review

Health Control Beliefs and Attitude Toward Treatment in Psychiatric and Non-Psychiatric Clinical Samples

An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance

Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder

Personalized medicine can pave the way for the safe use of CB1 receptor antagonists

Sick leave duration as a potential marker of functionality and disease severity in depression

Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitive Transcranial Magnetic Stimulation

Massive withdrawal symptoms and affective vulnerability are associated with variants of the CHRNA4 gene in a subgroup of smokers

Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressors

Investigation of circulating endothelial progenitor cells and angiogenic and inflammatory cytokines during recovery from an episode of major depression

Acute effects of the first period of COVID-19 pandemic on mental state

Highlights of peripheral biomarkers in major depressive disorder: focus on HPA-axis, inflammation and neurotrophic factors

A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes

Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review

From stone-craved genes to Michelangelo: significance and different aspects of gene-environment interaction

Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk

Smoking, nicotine and neuropsychiatric disorders

Pharmacological treatment and health control beliefs from the perspective of psychiatric patients: differences in attitudes

Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

New Evidence for the Association of the Serotonin Transporter Gene (SLC6A4) Haplotypes, Threatening Life Events, and Depressive Phenotype

Genetic analyses of the endocannabinoid pathway in association with affective phenotypic variants

Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype

Suchergebnisse filtern